Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Lindley

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylationS R Faucette, R L Hawke, S S Shord, et al.
Pharmacotherapy|September 1, 1996
Methotrexate elimination in a patient with an orthotopic neobladder with and without a urethral catheterP D Wire, R E Dupuis, J L Mohler, et al.
Journal of Pain and Symptom Management|July 9, 1998
Cancer pain survey: patient-centered issues in controlT E Thomason, J S McCune, S A Bernard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1992
Quality of life consequences of chemotherapy-induced emesisC M Lindley, J D Hirsch, C V O'Neill, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjectsG W Hogeland, S Swindells, J C McNabb, et al.
The Annals of Pharmacotherapy|February 24, 2001
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational studyJ S McCune, M D Oertel, D Pfeifer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activityS R Faucette, R L Hawke, E L Lecluyse, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Clinical Pharmacology and Therapeutics|June 1, 1994
Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylationS R Faucette, R L Hawke, S S Shord, et al.
Pharmacotherapy|September 1, 1996
Methotrexate elimination in a patient with an orthotopic neobladder with and without a urethral catheterP D Wire, R E Dupuis, J L Mohler, et al.
Journal of Pain and Symptom Management|July 9, 1998
Cancer pain survey: patient-centered issues in controlT E Thomason, J S McCune, S A Bernard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 1, 1992
Quality of life consequences of chemotherapy-induced emesisC M Lindley, J D Hirsch, C V O'Neill, et al.
Clinical Pharmacology and Therapeutics|December 23, 2006
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjectsG W Hogeland, S Swindells, J C McNabb, et al.
The Annals of Pharmacotherapy|February 24, 2001
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational studyJ S McCune, M D Oertel, D Pfeifer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activityS R Faucette, R L Hawke, E L Lecluyse, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Clinical Pharmacology and Therapeutics|June 1, 1994
Pharmacokinetics and pharmacodynamics of recombinant factor VIIaC M Lindley, W T Sawyer, B G Macik, et al.
Pageof 4